Literature DB >> 12407100

Bile acids stimulate cFLIP phosphorylation enhancing TRAIL-mediated apoptosis.

Hajime Higuchi1, Jung-Hwan Yoon, Annette Grambihler, Nathan Werneburg, Steven F Bronk, Gregory J Gores.   

Abstract

Bile acids induce hepatocyte injury by enhancing death receptor-mediated apoptosis. In this study, bile acid effects on TRAIL-mediated apoptosis were examined to gain insight into bile acid potentiation of death receptor signaling. TRAIL-induced apoptosis of HuH-7 cells, stably transfected with a bile acid transporter, was enhanced by bile acids. Caspase 8 and 10 activation, bid cleavage, cytosolic cytochrome c, and caspase 3 activation by TRAIL were all increased by the bile acid glycochenodeoxycholate (GCDCA). GCDCA (100 microm) did not alter expression of TRAIL-R1/DR4, TRAIL-R2/DR5, procaspase 8, cFLIP-L, cFLIP-s, Bax, Bcl-xL, or Bax. However, both caspase 8 and caspase 10 recruitment and processing within the TRAIL death-inducing signaling complex (DISC) were greater in GCDCA-treated cells whereas recruitment of cFLIP long and short was reduced. GCDCA stimulated phosphorylation of both cFLIP isoforms, which was associated with decreased binding to GST-FADD. The protein kinase C antagonist chelerythrine prevented bile acid-stimulated cFLIP-L and -s phosphorylation, restored cFLIP binding to GST-FADD, and attenuated bile acid potentiation of TRAIL-induced apoptosis. These results provide new insights into the mechanisms of bile acid cytotoxicity and the proapoptotic effects of cFLIP phosphorylation in TRAIL signaling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12407100     DOI: 10.1074/jbc.M209387200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

Review 1.  Hepatocyte death: a clear and present danger.

Authors:  Harmeet Malhi; Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

2.  S-nitrosylation of FLICE inhibitory protein determines its interaction with RIP1 and activation of NF-κB.

Authors:  Siera Jo Talbott; Sudjit Luanpitpong; Christian Stehlik; Neelam Azad; Anand Krishnan V Iyer; Liying Wang; Yon Rojanasakul
Journal:  Cell Cycle       Date:  2014-04-24       Impact factor: 4.534

3.  Association between TRAIL expression on peripheral blood lymphocytes and liver damage in chronic hepatitis B.

Authors:  Gong-Ying Chen; Jian-Qin He; Guo-Cai Lu; Ming-Wei Li; Chen-Huai Xu; Wei-Wei Fan; Chen Zhou; Zhi Chen
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

4.  Ursodeoxycholyl lysophosphatidylethanolamide inhibits cholestasis- and hypoxia-induced apoptosis by upregulating antiapoptosis proteins.

Authors:  Myra Sellinger; Weihong Xu; Anita Pathil; Wolfgang Stremmel; Walee Chamulitrat
Journal:  Exp Biol Med (Maywood)       Date:  2014-08-14

5.  Nod2 deficiency protects mice from cholestatic liver disease by increasing renal excretion of bile acids.

Authors:  Lirui Wang; Phillipp Hartmann; Michael Haimerl; Sai P Bathena; Christopher Sjöwall; Sven Almer; Yazen Alnouti; Alan F Hofmann; Bernd Schnabl
Journal:  J Hepatol       Date:  2014-02-19       Impact factor: 25.083

6.  Molecular mechanisms of GD3-induced apoptosis in U-1242 MG glioma cells.

Authors:  O M Omran; H E Saqr; Allan J Yates
Journal:  Neurochem Res       Date:  2006-10-17       Impact factor: 3.996

Review 7.  Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy.

Authors:  Ahmad R Safa; Travis W Day; Ching-Huang Wu
Journal:  Curr Cancer Drug Targets       Date:  2008-02       Impact factor: 3.428

8.  Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosis.

Authors:  M Marzioni; G Alpini; S Saccomanno; C Candelaresi; J Venter; C Rychlicki; G Fava; H Francis; L Trozzi; A Benedetti
Journal:  Gut       Date:  2008-10-01       Impact factor: 23.059

Review 9.  c-FLIP, a master anti-apoptotic regulator.

Authors:  A R Safa
Journal:  Exp Oncol       Date:  2012-10

10.  HIV induces TRAIL sensitivity in hepatocytes.

Authors:  Challagundla K Babu; Kanitta Suwansrinon; Gary D Bren; Andrew D Badley; Stacey A Rizza
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.